The purpose of this study is to determine if Belatacept is safe to give to adult heart
transplant recipients. Belatacept (NULOJIX) is an anti-rejection medication that is available
through a prescription from a doctor. In this research study, belatacept is being used in an
investigational manner (not for the purpose that it is approved for).